Showing results (101-110 of 3,795) with videos related to
Sort By:
Pageof 380
Renaissance Quarterly|June 10, 2010
Albertus, "Magnus" or Magus? Magic, natural philosophy, and religious reform in the late middle agesDavid J CollinsAdvances in Experimental Medicine and Biology|September 15, 2011
The RNA infrastructure: an introduction to ncRNA networksLesley J CollinsAdvances in Experimental Medicine and Biology|September 15, 2011
Spliceosomal RNA infrastructure: the network of splicing components and their regulation by miRNAsLesley J CollinsThe Journal of Clinical Investigation|November 1, 1986
Breakpoints on chromosomes 9 and 22 in Philadelphia chromosome-positive chronic myelogenous leukemia (CML). Amplification of rearranged c-abl oncogenes in CML blast crisisS J CollinsAmerican Journal of Orthopedics (Belle Mead, N.J.)|June 10, 2014
The impact patient-specific instrumentation has had on my practice in the last 5 yearsMichael J CollinsArchives of Disease in Childhood|December 1, 1992
Growth hormone deficiency during puberty reduces adult bone mineral densityS L Hyer, D A Rodin, J H Tobias, et al.Hospital & Community Psychiatry|June 1, 1984
Treatment characteristics of effective psychiatric programsJ F Collins, R B Ellsworth, N A Casey, et al.Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|January 1, 1989
Progression of diabetic retinopathy and changes in serum insulin-like growth factor I (IGF I) during continuous subcutaneous insulin infusion (CSII)S L Hyer, P S Sharp, M Sleightholm, et al.Acta Endocrinologica|February 1, 1989
Continuous subcutaneous octreotide infusion markedly suppresses IGF-I levels whilst only partially suppressing GH secretion in diabetics with retinopathyS L Hyer, P S Sharp, R A Brooks, et al.Metabolism: Clinical and Experimental|June 1, 1989
A two-year follow-up study of serum insulinlike growth factor-I in diabetics with retinopathyS L Hyer, P S Sharp, R A Brooks, et al.Pageof 380